AIRE and alopecia: Using this approach, we observed that the anti-CD45RC mAb inhibited the development of visible manifestations in Aire–/– animals compared with isotype control mAb–treated Aire–/– animals as evidenced by the absence of alopecia- and vitiligo-like symptoms (Figure 6B).